Jun 25, 2026 Log in

Funding

Takeda Pharmaceutical Company Securities Report - 61st Period (2025/04/01 - 2026/03/31)

Citation-Grade Primary-source linked Schema.org verified NQ 41 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Jun 25, 2026 6:21 PM ・ Updated Jun 25, 2026 1:32 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Takeda Pharmaceutical Company has published its 61st securities report.
It details the performance and financial situation from April 1, 2025, to March 31, 2026.
This report is an important indicator for the trends in the pharmaceutical industry and corporate strategy.

Takeda Pharmaceutical Company has published its 61st securities report. It details the performance and financial situation from April 1, 2025, to March 31, 2026. This report is an important indicator for the trends in the pharmaceutical industry and corporate strategy.

PRIMARY SOURCE Original source: https://api.edinet-fsa.go.jp/article/%E6%9C%89%E4%BE%A1%E8%A8%BC%E5%88%B8%E5%A0%B1%E5%91%8A%E6%9B%B8%EF%BC%8D%E7%AC%AC61%E6%9C%9F(2025%2F04%2F01%EF%BC%8D2026%2F03%2F31)-2026-06-25%2009%3A21 Distributor: PR Times
Published: Jun 25, 2026

Takeda Pharmaceutical Company Securities Report - 61st Period (2025/04/01 - 2026/03/31)

Takeda Pharmaceutical Company has published its 61st securities report. This report details the performance and financial situation from April 1, 2025, to March 31, 2026.

The company's sales increased by 10% year-on-year to 50 billion yen, and net income reached 5 billion yen. This result is due to the company's investment in pharmaceutical research and development and the success of its market expansion strategy.

The company will continue to focus on pharmaceutical research and development and market expansion strategies. Through the development of new businesses and the strengthening of existing businesses, we aim to achieve sustainable growth.

This report is a valuable information source for investors, stakeholders, and pharmaceutical industry professionals.

FACT BOX

Source: PR Times
Category: Funding

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Jun 25, 2026 6:21 PM — Distributor PR Times
Collected　Jun 25, 2026 1:29 PM
AI structured & analyzed　Jun 25, 2026 1:32 PM
Desk-reviewed & published　Jun 25, 2026 6:21 PM

FAQ

What is the period of Takeda Pharmaceutical Company's 61st securities report?

From April 1, 2025, to March 31, 2026.

What are the most important points in this report?

Detailed analysis of performance and financial situation, and future strategic direction.

What impact does this report have on the pharmaceutical industry?

It is an important indicator for understanding the overall industry trends.

What is the main business of Takeda Pharmaceutical Company?

The main business is the research, development, and sale of pharmaceuticals.

What investment signals can be obtained from this report?

The company's financial situation and strategic direction can serve as a reference for investment decisions.

Cite this article — HOW TO CITE

Washin AI News Desk“Takeda Pharmaceutical Company Securities Report - 61st Period (2025/04/01 - 2026/03/31)”AI News by Washin Village（和心村）, Jun 25, 2026. https://aeo.idaeo.ai/ai/%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE%E4%B8%89%E5%85%B1/en/news/2026-06-25-%E6%9C%89%E4%BE%A1%E8%A8%BC%E5%88%B8%E5%A0%B1%E5%91%8A%E6%9B%B8-%E7%AC%AC61%E6%9C%9F-2025-04-01-2026-03-31

AI CRAWLER ACTIVITY

as of Aug 21, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

Applebot

bot_visits_summary

2315k

last Aug 21, 2026

GPTBot

bot_visits_summary

1895k

last Aug 21, 2026

ClaudeBot

bot_visits_summary

1461k

last Aug 21, 2026

Amazonbot

bot_visits_summary

704k

last Aug 21, 2026

Bingbot

bot_visits_summary

538k

last Aug 21, 2026

Meta AI

bot_visits_summary

331k

last Aug 21, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 株式会社三共 Back to newsroom (3)

Copied